PHENYLKETONURIA (PKU)
Clinical trials for PHENYLKETONURIA (PKU) explained in plain language.
Never miss a new study
Get alerted when new PHENYLKETONURIA (PKU) trials appear
Sign up with your email to follow new studies for PHENYLKETONURIA (PKU), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for PKU shows promise in small teen trial
Disease control CompletedThis study tested a new drug called JNT-517 in 14 teenagers with phenylketonuria (PKU). Participants took either JNT-517 or a placebo twice daily for 28 days. The main goal was to check safety and how the drug moves through the body, while also measuring changes in blood phenylal…
Matched conditions: PHENYLKETONURIA (PKU)
Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Tiny tablet, big hope: new PKU supplement put to the test
Disease control CompletedThis study tested a new microtablet supplement called PKU EASY Microtabs Plus in 10 people with PKU aged 3 and older. The supplement is a slow-release protein substitute designed to help manage PKU. Over one week, researchers checked how well participants tolerated it (stomach is…
Matched conditions: PHENYLKETONURIA (PKU)
Phase: NA • Sponsor: Galen Limited • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC